Legend Biotech (LEGN) Earnings Date, Estimates & Call Transcripts → Bill Clinton Backing Biden Replacement??? (From The Freeport Society) (Ad) Free LEGN Stock Alerts $43.24 -2.28 (-5.01%) (As of 05/10/2024 08:55 PM ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Earnings SummaryLatest Earnings DateMay. 13ConfirmedConsensus EPS (May. 13) -$0.23 Listen to Call Get Legend Biotech Earnings AlertsEnter your email address below to receive the latest news and earnings results for LEGN and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueLEGN Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.LEGN Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Gold Safe ExchangeTrump’s “Tax Free” Retirement Strategy Since 1924 — over one hundred years — the US dollar has lost nearly 18x its value. In other words, a dollar back then would buy $17.82 worth of goods in today's money. If you're planning on retiring any time soon…This poses a real problem.Protect your retirement savings from the inevitable devaluation of the dollar… Legend Biotech Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20242($0.62)($0.01)($0.32)Q2 20242($0.62)($0.12)($0.37)Q3 20242($0.54)($0.18)($0.36)Q4 20242($0.54)($0.13)($0.34)FY 20248($2.32)($0.44)($1.38)Q1 20251($0.30)($0.30)($0.30)LEGN Earnings Date and InformationLegend Biotech last released its quarterly earnings results on May 13th, 2024. The reported $0.00 EPS for the quarter, topping the consensus estimate of ($0.23) by $0.23. Legend Biotech has generated ($1.48) earnings per share over the last year (($1.48) diluted earnings per share). Earnings for Legend Biotech are expected to grow in the coming year, from ($1.60) to $0.08 per share. Legend Biotech has confirmed that its next quarterly earnings report will be published on Monday, May 13th, 2024. Legend Biotech will be holding an earnings conference call on Monday, May 13th at 8:00 AM Eastern. Interested parties can register for or listen to the call.. Read More Legend Biotech Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 5/13/2024Confirmed)-($0.23)----- 3/11/2024Q4 2023($0.70)($0.40)+$0.30($0.40)$95.63 million$76.50 million 11/20/2023Q3 2023($0.31)($0.17)+$0.14($0.17)$97.25 million$96.00 million 8/15/2023Q2 2023($0.36)($0.57)($0.21)$0.03$56.64 million$73.30 million5/18/2023Q1 2023($0.56)($0.40)+$0.16($0.46)$37.06 million$36.34 million2/17/2023Q2 2022-($0.41)($0.41)($0.20)-$11.97 million6/1/2022Q1 2022($0.37)($0.24)+$0.13($0.35)$46.67 million$40.83 million Get the Latest News and Ratings for LEGN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Legend Biotech and its competitors with MarketBeat's FREE daily newsletter. 3/18/2022Q4 2021($0.35)($0.38)($0.03)($0.46)$13.23 million$39.00 million11/16/2021Q3 2021($0.35)($0.43)($0.08)($0.43)$12.50 million$16.88 million8/22/2021Q2 2021($0.34)($0.64)($0.30)($0.31)$12.50 million$20.23 million5/17/2021Q1 2021($0.35)($0.30)+$0.05($0.30)$12.50 million$13.68 million Legend Biotech Earnings - Frequently Asked Questions When is Legend Biotech's earnings date? Legend Biotech has confirmed that its next quarterly earnings data will be published on Monday, May 13th, 2024. Learn more on LEGN's earnings history. Did Legend Biotech beat their earnings estimates last quarter? In the previous quarter, Legend Biotech (NASDAQ:LEGN) reported $0.00 earnings per share (EPS) to beat the analysts' consensus estimate of ($0.23) by $0.23. Learn more on analysts' earnings estimate vs. LEGN's actual earnings. How can I listen to Legend Biotech's earnings conference call? The conference call for Legend Biotech's latest earnings report can be listened to online. Listen to Conference Call How much revenue does Legend Biotech generate each year? Legend Biotech (NASDAQ:LEGN) has a recorded annual revenue of $285.14 million. How much profit does Legend Biotech generate each year? Legend Biotech (NASDAQ:LEGN) has a recorded net income of -$518.25 million. LEGN has generated -$1.48 earnings per share over the last four quarters. What is Legend Biotech's EPS forecast for next year? Legend Biotech's earnings are expected to grow from ($1.60) per share to $0.08 per share in the next year. More Earnings Resources from MarketBeat Related Companies: VKTX Earnings Results ASND Earnings Results CERE Earnings Results ROIV Earnings Results JAZZ Earnings Results ITCI Earnings Results CYTK Earnings Results ELAN Earnings Results BPMC Earnings Results CTLT Earnings Results Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: Traders Sell but Investors Still Win After Palantir's EarningsTech Earnings Insights: Where Opportunity Meets UncertaintyApple’s Earnings Show Investors Its Strength and Its WeaknessCarvana’s Q1 Earnings: A Profitability U-TurnPayPal’s Strong Earnings Growth and Strategic Evolution GE Aerospace is Ready for Liftoff After Strong EarningsTaiwan Semiconductor Earnings: AI Dominance and Future Outlook This page (NASDAQ:LEGN) was last updated on 5/13/2024 by MarketBeat.com Staff From Our PartnersBill Clinton Backing Biden Replacement???The Freeport SocietyThe Department of Defense Has a New Drone ContractorThe Tomorrow InvestorDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithThe Crypto 9-5 Escape PlanCrypto 101 MediaThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldGold Set to EXPLODE!Gold Safe ExchangeConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial Metals Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Legend Biotech Co. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.